Animal studies have shown that monosodium glutamate intake increases the risk of obesity [54], probably through increasing the palatability of food by disrupting the hypothalamic signaling cascade of leptin action [15, 55]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.